Harbin Fuerjia Technology Co., Ltd.

SZSE:301371 Stock Report

Market Cap: CN¥14.5b

Harbin Fuerjia Technology Valuation

Is 301371 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301371 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301371 (CN¥36.18) is trading above our estimate of fair value (CN¥19.14)

Significantly Below Fair Value: 301371 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301371?

Key metric: As 301371 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 301371. This is calculated by dividing 301371's market cap by their current earnings.
What is 301371's PE Ratio?
PE Ratio19.9x
EarningsCN¥726.81m
Market CapCN¥14.47b

Price to Earnings Ratio vs Peers

How does 301371's PE Ratio compare to its peers?

The above table shows the PE ratio for 301371 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average23x
688029 Micro-Tech (Nanjing)Ltd
25.3x19.0%CN¥13.7b
600529 Shandong Pharmaceutical GlassLtd
19.1x18.4%CN¥16.8b
300595 Autek China
27.2x16.8%CN¥17.5b
688016 Shanghai MicroPort Endovascular MedTech
20.3x20.3%CN¥12.8b
301371 Harbin Fuerjia Technology
19.9x8.4%CN¥14.5b

Price-To-Earnings vs Peers: 301371 is good value based on its Price-To-Earnings Ratio (19.9x) compared to the peer average (23x).

Price to Earnings Ratio vs Industry

How does 301371's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
301371 19.9xIndustry Avg. 36.1xNo. of Companies14PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 301371 is good value based on its Price-To-Earnings Ratio (19.9x) compared to the CN Medical Equipment industry average (36.1x).

Price to Earnings Ratio vs Fair Ratio

What is 301371's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301371 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19.9x
Fair PE Ratio21.5x

Price-To-Earnings vs Fair Ratio: 301371 is good value based on its Price-To-Earnings Ratio (19.9x) compared to the estimated Fair Price-To-Earnings Ratio (21.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 301371 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥36.18
CN¥42.50
+17.5%
4.8%CN¥45.00CN¥40.00n/a3
Nov ’25CN¥35.06
CN¥42.50
+21.2%
4.8%CN¥45.00CN¥40.00n/a3
Oct ’25CN¥37.15
CN¥39.02
+5.0%
6.3%CN¥42.50CN¥37.00n/a3
Sep ’25CN¥28.35
CN¥39.02
+37.6%
6.3%CN¥42.50CN¥37.00n/a3
Aug ’25CN¥28.20
CN¥42.93
+52.2%
7.0%CN¥47.00CN¥39.78n/a3
Jul ’25CN¥31.73
CN¥42.93
+35.3%
7.0%CN¥47.00CN¥39.78n/a3
Jun ’25CN¥33.03
CN¥42.93
+30.0%
7.0%CN¥47.00CN¥39.78n/a3
May ’25CN¥34.59
CN¥42.93
+24.1%
7.0%CN¥47.00CN¥39.78n/a3
Apr ’25CN¥33.75
CN¥51.50
+52.6%
8.7%CN¥56.00CN¥47.00n/a2
Mar ’25CN¥31.71
CN¥51.50
+62.4%
8.7%CN¥56.00CN¥47.00n/a2
Feb ’25CN¥29.35
CN¥51.50
+75.5%
8.7%CN¥56.00CN¥47.00n/a2
Jan ’25CN¥38.21
CN¥51.50
+34.8%
8.7%CN¥56.00CN¥47.00n/a2

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥7.1b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥16.71

7D

-4.2%

1Y

-27.4%

Innovita Biological Technology

CN¥5.7b

Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.

688253

CN¥42.13

7D

-4.5%

1Y

64.8%

Winner Medical

CN¥20.0b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥34.29

7D

3.7%

1Y

-13.6%